Award
National Institute of Allergy and Infectious Diseases (NIAID) 11141678
Reducing malaria in pregnancy through focal drug administration in household members: A pilot feasibility trial
Recipient
UNIV OF NORTH CAROLINA CHAPEL HILL
Award Amount
$41,565.00
Ceiling
$41,565.00
Awarded
August 06, 2025
Identifier
11141678
This award funds a pilot trial in Uganda to evaluate a drug administration strategy to reduce malaria in pregnancy, aiming to assess feasibility and efficacy.
Description
A pilot randomized controlled trial in rural western Uganda to assess the feasibility, acceptability, and efficacy of focal mass drug administration (fMDA) with dihydroartemisinin-piperaquine (DP) to prevent malaria in pregnancy, including longitudinal assessments of malaria infection and birth outcomes.